Perpetuum CropScience
ActiveSummary
The computed 12-month bankruptcy probability of Perpetuum CropScience is 12.0% (high). The 2025 annual accounts show negative equity (-€65,256) and a net result of -€31,491. Equity is shrinking by about 67% per year across the filed financial years. Its solvency ranks better than 9% of 605 sector peers (NACE 72, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
01-10
NBB filing
Annual accounts filed
financial year 2025 · micro format · 62 days late
03-03
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 12-11-2025
- Registered-office move, Schaarbeekstraat 20D / 1, 9120 Beveren-Kruibeke-Zwijndrecht
2025
22-12
KBO administration
Address struck
30-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 61 days late
27-05
NBB filing
Annual accounts filed
financial year 2023 · micro format · 300 days late
27-05
NBB filing
Annual accounts filed
financial year 2022 · micro format · 666 days late
2022
24-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial
Weakest financial yearnet -€38,001
Net result drops to -€38,001, the lowest in the series; recovery starts the following year.
27-10
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format · 88 days late
2020
31-12
Financial
Highest result from 2019 to 2025net €30,706 ▲77.1%
Operating result €36,238, net result €30,706, both a record.
27-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
SignalFinancial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.